To access this element change to forms mode OFF
Grant Award View - GA320146
Drug Target Identification Platform
GA ID:
GA320146
Agency:
Department of Health and Aged Care
Approval Date:
27-Mar-2023
Publish Date:
5-Jul-2023
Category:
Medical Research
Grant Term:
15-Jun-2023 to 6-Dec-2028
Value (AUD):
$2,927,359.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Drug Target Identification Platform
Purpose:
| This platform will identify and validate the molecular targets of new drug candidates to enable their further optimisation and development. State-of-the-art mass spectrometry will underpin advanced proteomics and metabolomics approaches, supported by transcriptomics and functional genomics approaches, to identify drug targets within cells and monitor pharmacodynamic biomarkers that support progression of drug candidates through pre-clinical and clinical development. This capability will fill an important gap in the Australian drug discovery landscape, and accelerate the pharmaceutical development and commercialisation of many of the fundamental biomedical discoveries arising from our academic and small pharmaceutical entities. |
GO ID:
GO Title:
MRFF 2022 National Critical Research Infrastructure Grant Opportunity
Internal Reference ID:
MRFCRI000102
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
MONASH UNIVERSITY
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
MOUNT WAVERLY
Town/City:
MOUNT WAVERLY
Postcode:
3149
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3052
Country:
AUSTRALIA